A coding single-nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitors

赖氨酸脱甲基酶 KDM4A 的编码单核苷酸多态性与对 mTOR 抑制剂的敏感性增加有关

阅读:5
作者:Capucine Van Rechem, Joshua C Black, Patricia Greninger, Yang Zhao, Carlos Donado, Paul D Burrowes, Brendon Ladd, David C Christiani, Cyril H Benes, Johnathan R Whetstine

Significance

This report documents the first coding SNP within a lysine demethylase that associates with worse outcome in patients with NSCLC. We demonstrate that this coding SNP alters the protein turnover and associates with increased mTOR inhibitor sensitivity, which identifies a candidate biomarker for mTOR inhibitor therapy and a therapeutic target for combination therapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。